CD274 and colorectal cancer: On the contrary, PD-L1 overexpression was found to be associated with better prognosis in non-small cell lung cancer (NSCLC), colorectal cancer, pancreatic cancer, breast cancer, and Merkel cell carcinoma [29–34].